Understanding the Alterations in Lipid Metabolism in NAFLD Progression: Current Trends and Future Directions

Authors:

Abstract
Non-alcoholic fatty liver disease (NAFLD) is a pathological condition, wherein the fat deposition exceeds the allowable limits of the healthy person. If the condition is pursued for a long time, the patient will eventually develop into NASH (non-alcoholic steatohepatitis) and probably into HCC (hepatocellular carcinoma). The incidence of NAFLD is rising at an alarming rate, and still, there are no FDA-approved drugs for this devastating health condition. To combat and treat NAFLD successfully, it is essential to understand how a routine lipid metabolism in the liver is altered under these conditions. In this review, we discuss specifically during the NAFLD progression, how the signaling pathways leading to excess fat accumulation in the liver are altered, variations in the hepatic lipid uptake mechanisms as well as changes in fatty acid oxidation mechanisms. We will also highlight the role of transcription factors and other lipolytic enzymes that stringently regulate the hepatic de novo lipolysis (DNL) and emphasize how they are altered during the NAFLD progression. Finally, we will also touch upon how the lipid disposal form the liver goes wrong during the NAFLD progression. A comprehensive understanding of the altered lipid metabolism is essential for the development of successful therapy against NAFLD.